Shareholders' Equity (Tables)

6 Months Ended

Jun. 30, 2020

Equity [Abstract]

Schedule of employees and directors' stock option activity

	Number of options			Weighted average exercise price		Weighted average remaining contractual term (years)		Aggregate intrinsic value
Outstanding at December 31, 2019		7,299,667		$	2.16		3.81	$	-
Granted		96,500			1.18
Exercised		-			-
Expired and forfeited		(729,108	)		2.64
Outstanding at June 30, 2020		6,667,059		$	2.10		3.53	$	4
Options vested and expected to vest at June 30, 2020		6,434,586		$	2.10		3.48	$	4
Exercisable options at June 30, 2020		3,871,797		$	2.23		2.54	$	-
Weighted average fair value of options granted during the quarter				$	0.47

Schedule of employee and director options outstanding

Outstanding							Exercisable
			Weighted average remaining contractual		Weighted average exercise				Weighted average exercise
	Options		life in		price per		Options		price per
Exercise price per share	outstanding		years		share		exercisable		share
$1.06 - $1.64		1,599,721		4.01	$	1.56		500,221	$	1.46
$1.70 - $2.00		1,599,860		3.31	$	1.87		1,180,775	$	1.93
$2.05 - $2.29		1,447,490		4.22	$	2.10		641,840	$	2.10
$2.30 - $2.75		898,662		3.74	$	2.39		529,200	$	2.37
$2.90 - $3.20		1,121,326		2.09	$	2.97		1,019,761	$	2.97
		6,667,059		3.53	$	2.10		3,871,797	$	2.23

Schedule of options to non-employees

Issuance date	Options outstanding		Exercise price per share		Options exercisable		Exercisable through
February 18, 2015		3,000	$	3.00		3,000	Feb-21
February 10, 2016		40,000	$	1.44		40,000	Feb-22
January 24, 2017		25,000	$	2.00		25,000	Jan-23
		68,000				68,000

Schedule of RSUs activity

	Number of RSUs			Weighted average grant date fair value
Awarded and unvested at December 31, 2019		1,733,132		$	2.09
Granted		514,000			1.30
Vested		(631,132	)		2.49
Forfeited		(42,500	)		2.30
Awarded and unvested at June 30, 2020		1,573,500		$	1.66

Schedule of stock-based compensation expense

	Three months ended June 30,				Six months ended June 30
	2020		2019		2020		2019
	Unaudited				Unaudited
Cost of revenues	$	20	$	33	$	64		62
Research and development		64		58		159		125
Sales and marketing		43		48		139		97
General and administrative		380		175		790		299
	$	507	$	314	$	1,152	$	583